FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968361163> ?p ?o ?g. }

• W2968361163 endingPage "2616" @default.
• W2968361163 startingPage "2608" @default.
• W2968361163 abstract "Purpose To determine in a prospective, randomized fashion whether liposomal bupivacaine extends the effectiveness of decreased pain scores and reduces narcotic requirements following hip arthroscopy when used in addition to a fascia iliaca blockade with plain bupivacaine alone. Methods Double-blinded prospective randomized controlled trial of participants undergoing hip arthroscopy. Randomized to receive a fascia iliaca blockade with 40 mL 0.25% plain bupivacaine (100 mg; control group) or 20 mL 0.5% plain bupivacaine (100 mg) plus 20 mL liposomal bupivacaine (266 mg; study group). The primary outcome was Defense and Veterans Pain Rating Scale (DVPRS) scores in the postanesthesia care unit and on postoperative days (POD) 1, 2, 3, and 14. Secondary outcomes included postoperative opioid consumption and subjective loss of anterior thigh sensation. Results Seventy-four patients were enrolled, and 70 completed the study; 37 were randomized to the control group and 33 to the study group. There was no significant difference in postoperative DVPRS scores at any time point. There was no significant difference in total postoperative opioid use during any postoperative time points. While most patients reported anterior thigh numbness at discharge, significantly more patients in the study group reported anterior thigh numbness at POD2 (control, 19/37 numb vs study, 32/33 numb; P < .0001) and at POD3 (control, 8/37 numb vs study, 26/33 numb; P < .0001). Conclusions In this prospective evaluation comparing plain bupivacaine versus the liposomal formulation administered via a fascia iliaca blockade there were no significant differences in postoperative pain scores and narcotic pill usage. Given the highly significant findings of prolonged anterior thigh numbness out to POD3 in patients who received liposomal bupivacaine, this formulation did exhibit prolonged effects; however, it did not provide improved pain control when used in this surgical population, likely due to the innervation of the hip capsule from differential nerve plexi. Given the 6-fold increased cost of using the liposomal formulation, we are unable to recommend its use via a fascia iliaca blockade for hip arthroscopy. Level of Evidence Level I, therapeutic study. To determine in a prospective, randomized fashion whether liposomal bupivacaine extends the effectiveness of decreased pain scores and reduces narcotic requirements following hip arthroscopy when used in addition to a fascia iliaca blockade with plain bupivacaine alone. Double-blinded prospective randomized controlled trial of participants undergoing hip arthroscopy. Randomized to receive a fascia iliaca blockade with 40 mL 0.25% plain bupivacaine (100 mg; control group) or 20 mL 0.5% plain bupivacaine (100 mg) plus 20 mL liposomal bupivacaine (266 mg; study group). The primary outcome was Defense and Veterans Pain Rating Scale (DVPRS) scores in the postanesthesia care unit and on postoperative days (POD) 1, 2, 3, and 14. Secondary outcomes included postoperative opioid consumption and subjective loss of anterior thigh sensation. Seventy-four patients were enrolled, and 70 completed the study; 37 were randomized to the control group and 33 to the study group. There was no significant difference in postoperative DVPRS scores at any time point. There was no significant difference in total postoperative opioid use during any postoperative time points. While most patients reported anterior thigh numbness at discharge, significantly more patients in the study group reported anterior thigh numbness at POD2 (control, 19/37 numb vs study, 32/33 numb; P < .0001) and at POD3 (control, 8/37 numb vs study, 26/33 numb; P < .0001). In this prospective evaluation comparing plain bupivacaine versus the liposomal formulation administered via a fascia iliaca blockade there were no significant differences in postoperative pain scores and narcotic pill usage. Given the highly significant findings of prolonged anterior thigh numbness out to POD3 in patients who received liposomal bupivacaine, this formulation did exhibit prolonged effects; however, it did not provide improved pain control when used in this surgical population, likely due to the innervation of the hip capsule from differential nerve plexi. Given the 6-fold increased cost of using the liposomal formulation, we are unable to recommend its use via a fascia iliaca blockade for hip arthroscopy." @default.
• W2968361163 created "2019-08-22" @default.
• W2968361163 creator A5029171972 @default.
• W2968361163 creator A5031564473 @default.
• W2968361163 creator A5034223575 @default.
• W2968361163 creator A5039126522 @default.
• W2968361163 creator A5051907843 @default.
• W2968361163 creator A5061194650 @default.
• W2968361163 creator A5064453707 @default.
• W2968361163 creator A5067503091 @default.
• W2968361163 date "2019-09-01" @default.
• W2968361163 modified "2023-09-23" @default.
• W2968361163 title "Fascia Iliaca Blockade With the Addition of Liposomal Bupivacaine Versus Plain Bupivacaine for Perioperative Pain Management During Hip Arthroscopy: A Double-Blinded Prospective Randomized Control Trial" @default.
• W2968361163 cites W1550245501 @default.
• W2968361163 cites W1881181639 @default.
• W2968361163 cites W1929228473 @default.
• W2968361163 cites W1993463607 @default.
• W2968361163 cites W2007831691 @default.
• W2968361163 cites W2013458750 @default.
• W2968361163 cites W2050793244 @default.
• W2968361163 cites W2065572714 @default.
• W2968361163 cites W2070139935 @default.
• W2968361163 cites W2094012515 @default.
• W2968361163 cites W2095175406 @default.
• W2968361163 cites W2153744445 @default.
• W2968361163 cites W2279922238 @default.
• W2968361163 cites W2323650991 @default.
• W2968361163 cites W2414119946 @default.
• W2968361163 cites W2460830038 @default.
• W2968361163 cites W2526572126 @default.
• W2968361163 cites W2562272005 @default.
• W2968361163 cites W2588690024 @default.
• W2968361163 cites W2604583961 @default.
• W2968361163 cites W2738960566 @default.
• W2968361163 cites W2761668702 @default.
• W2968361163 cites W4253560202 @default.
• W2968361163 cites W2788243984 @default.
• W2968361163 doi "https://doi.org/10.1016/j.arthro.2019.03.056" @default.
• W2968361163 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31402223" @default.
• W2968361163 hasPublicationYear "2019" @default.
• W2968361163 type Work @default.
• W2968361163 sameAs 2968361163 @default.
• W2968361163 citedByCount "22" @default.
• W2968361163 countsByYear W29683611632019 @default.
• W2968361163 countsByYear W29683611632020 @default.
• W2968361163 countsByYear W29683611632021 @default.
• W2968361163 countsByYear W29683611632022 @default.
• W2968361163 countsByYear W29683611632023 @default.
• W2968361163 crossrefType "journal-article" @default.
• W2968361163 hasAuthorship W2968361163A5029171972 @default.
• W2968361163 hasAuthorship W2968361163A5031564473 @default.
• W2968361163 hasAuthorship W2968361163A5034223575 @default.
• W2968361163 hasAuthorship W2968361163A5039126522 @default.
• W2968361163 hasAuthorship W2968361163A5051907843 @default.
• W2968361163 hasAuthorship W2968361163A5061194650 @default.
• W2968361163 hasAuthorship W2968361163A5064453707 @default.
• W2968361163 hasAuthorship W2968361163A5067503091 @default.
• W2968361163 hasConcept C141071460 @default.
• W2968361163 hasConcept C168563851 @default.
• W2968361163 hasConcept C188816634 @default.
• W2968361163 hasConcept C2775849661 @default.
• W2968361163 hasConcept C2778446825 @default.
• W2968361163 hasConcept C2779162959 @default.
• W2968361163 hasConcept C2780485590 @default.
• W2968361163 hasConcept C2780820201 @default.
• W2968361163 hasConcept C2781328992 @default.
• W2968361163 hasConcept C31174226 @default.
• W2968361163 hasConcept C42219234 @default.
• W2968361163 hasConcept C71924100 @default.
• W2968361163 hasConceptScore W2968361163C141071460 @default.
• W2968361163 hasConceptScore W2968361163C168563851 @default.
• W2968361163 hasConceptScore W2968361163C188816634 @default.
• W2968361163 hasConceptScore W2968361163C2775849661 @default.
• W2968361163 hasConceptScore W2968361163C2778446825 @default.
• W2968361163 hasConceptScore W2968361163C2779162959 @default.
• W2968361163 hasConceptScore W2968361163C2780485590 @default.
• W2968361163 hasConceptScore W2968361163C2780820201 @default.
• W2968361163 hasConceptScore W2968361163C2781328992 @default.
• W2968361163 hasConceptScore W2968361163C31174226 @default.
• W2968361163 hasConceptScore W2968361163C42219234 @default.
• W2968361163 hasConceptScore W2968361163C71924100 @default.
• W2968361163 hasIssue "9" @default.
• W2968361163 hasLocation W29683611631 @default.
• W2968361163 hasLocation W29683611632 @default.
• W2968361163 hasOpenAccess W2968361163 @default.
• W2968361163 hasPrimaryLocation W29683611631 @default.
• W2968361163 hasRelatedWork W1982629652 @default.
• W2968361163 hasRelatedWork W1991846282 @default.
• W2968361163 hasRelatedWork W2035576628 @default.
• W2968361163 hasRelatedWork W2036687483 @default.
• W2968361163 hasRelatedWork W2049917025 @default.
• W2968361163 hasRelatedWork W2050802382 @default.
• W2968361163 hasRelatedWork W2320963474 @default.
• W2968361163 hasRelatedWork W2432366219 @default.
• W2968361163 hasRelatedWork W4205770490 @default.
• W2968361163 hasRelatedWork W4249599702 @default.
• W2968361163 hasVolume "35" @default.
• W2968361163 isParatext "false" @default.

• next